Medically reviewed by Danielle Weiss, MD After losing extra pounds on Ozempic (semaglutide), some are finding themselves ...

What’s happening in California, the impact of Ozempic, a look at some franchisee valuations, Greg Flynn’s thoughts on ...

Bluesky smiling at Lizzo, nothing but Bluesky does she see. As countless former X users have been flocking to the alternative ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

Results from the SURMOUNT-1 trial show that weekly injections of tirzepatide could stop the progression from pre-diabetes to ...

With new weight-loss drugs hailed as ‘miracle’ medicines, Harriet Symonds explores whether their increasing popularity should ...

As a new study finds that people who stopped taking semaglutide, the active ingredient in the new blockbuster weight loss ...

At an event in Rosemont, CBP highlighted everything from fake Ozempic to fake luxury good and guns ... Made to Order and Never in Danger of Leaving Bluesky has added 1 million users since election as ...

While another user wondered if the actors experienced drug-induced weight loss during the shoot of their musical film. “Were ...

GLP-1 drugs have been linked to numerous potential health benefits like treatment of existing conditions including heart ...

Hims & Hers Health launched a GLP-1 Supply Tracker to spotlight challenges in accessing obesity medications, addressing ...

This is just a glimpse of the GLP-1 insights available to CivicScience clients. Want to see the full picture? Let’s talk.